Israel National News | 29 Aug 2021
Natural immunity that develops after SARS-CoV-2 infection offers considerably better protection against the “Delta variant” than does two doses of the Pfizer-BioNTech vaccine, an Israeli study found.
The study relies on data from Israel’s Maccabi Health Services, and was conducted by researchers from Maccabi and Tel Aviv University. A preprint of the study, which has not yet been peer-reviewed, was published last week on medRxiv.
According to Science Magazine, the study found that “never-infected people who were vaccinated in January and February were, in June, July, and the first half of August, six to 13 times more likely to get infected than unvaccinated people who were previously infected with the coronavirus.”
